Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
R&D to Revenue
6.04%
Quarterly · Period ending:
TEVA R&D to Revenue
Latest reported6.04%period ending
Latest reported6.04%period ending
TEVA Quarterly R&D/Revenue (0.00% → 6.04%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.0357% | |
| 5.5765% | |
| 5.6676% | |
| 5.7143% | |
| 5.8429% | |
| 6.348% | |
| 6.4081% | |
| 5.5414% | |
| 6.4601% | |
| 6.3367% | |
| 5.2502% | |
| 6.5714% | |
| 7.0913% | |
| 6.9107% | |
| 5.4082% | |
| 4.8679% | |
| 6.0222% | |
| 6.1459% | |
| 5.9512% | |
| 5.7113% | |
| 6.3427% | |
| 6.3787% | |
| 8.5785% | |
| 6.4857% | |
| 5.814% | |
| 5.0723% | |
| 8.3725% | |
| 5.6285% | |
| 6.3638% | |
| 6.0768% | |
| 6.4707% | |
| 6.8669% | |
| 6.1689% | |
| 6.2586% | |
| 6.5946% | |
| 9.7148% | |
| 8.5473% | |
| 8.1172% | |
| 10.536% | |
| 11.918% | |
| 7.4434% | |
| 8.0873% | |
| 9.1375% | |
| 7.485% | |
| 7.7729% | |
| 6.664% | |
| 7.3336% | |
| 8.1455% | |
| 6.8186% | |
| 7.0586% | |
| 7.5691% | |
| 6.8788% | |
| 6.8846% | |
| 6.7129% | |
| 8.4207% | |
| 6.5165% | |
| 5.9672% | |
| 5.7232% | |
| 6.8006% | |
| 5.2256% | |
| 5.7692% | |
| 5.8578% | |
| 6.1114% | |
| 5.6235% | |
| 5.7105% | |
| 5.7761% | |
| 5.7601% | |
| 5.493% | |
| 4.9706% | |
| 6.959% | |
| 56.7767% | |
| 6.8262% | |
| 7.0138% | |
| 6.9596% | |
| 6.5217% | |
| 5.9594% | |
| 5.7418% | |
| 6.4904% | |
| 6.0288% | |
| 5.8757% | |
| 5.5515% | |
| 6.1465% | |
| 6.9807% | |
| 7.0143% | |
| 7.3745% | |
| 6.7591% | |
| 7.0079% | |
| 7.2477% | |
| 7.4124% | |
| 6.4709% | |
| 6.7728% | |
| 6.7438% | |
| 6.3448% | |
| 6.1262% | |
| 6.8164% | |
| 6.4312% | |
| 6.4336% | |
| 6.4392% | |
| 5.2151% | |
| 4.4493% |